These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 319244)

  • 1. Effect of isonicotinic acid hydrazide on the intratumor injection of BCG.
    Sparks FC; Albert NE; Breeding JH
    J Natl Cancer Inst; 1977 Feb; 58(2):367-8. PubMed ID: 319244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV
    J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental cancer immunotherapy: modification of tumor cells to increase immunogenicity.
    Rios A; Simmons RL
    Ann N Y Acad Sci; 1976; 276():45-60. PubMed ID: 68699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of cancer: induction of tumor immunity with a mixture of tumor cell-BCG, and the effect of intratumor injection of BCG and of nonliving BCG preparation.
    Tanaka T; Saito T
    Gan; 1975 Dec; 66(6):631-40. PubMed ID: 1225716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does isoniazid decrease the effect of BCG on local tumor growth?
    Sparks FC; Albert NE
    Surg Forum; 1975; 26():162-4. PubMed ID: 1216099
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship between intradermal tumor suppression and tumor immunity.
    Bartlett GL; Kreider JW; Purnell DM
    J Natl Cancer Inst; 1976 Dec; 57(6):1297-303. PubMed ID: 794505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapeutic effectiveness of BCG inactivated by various modalities.
    Kreider JW; Bartlett GL; Purnell DM
    Cancer; 1980 Aug; 46(3):480-7. PubMed ID: 7397622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
    Kreider JW; Bartlett GL; Purnell DM; Webb S
    Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suitability of rat mammary adenocarcinoma 13762 as a model for BCG immunotherapy.
    Kreider JW; Bartlett GL; Purnell DM
    J Natl Cancer Inst; 1976 Apr; 56(4):797-802. PubMed ID: 815563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
    Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
    [No Abstract]   [Full Text] [Related]  

  • 11. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
    Kreider JW; Bartlett GL; Boyer CM; Purnell DM
    Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalase-peroxidase of Mycobacterium bovis BCG converts isoniazid to isonicotinamide, but not to isonicotinic acid: differentiation parameter between enzymes of Mycobacterium bovis BCG and Mycobacterium tuberculosis.
    Kang SK; Lee JH; Lee YC; Kim CH
    Biochim Biophys Acta; 2006 May; 1760(5):724-9. PubMed ID: 16563633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative intralesional Bacillus Calmette-Guérin for mammary adenocarcinoma in rats.
    Lee YT
    Cancer Res; 1977 Oct; 37(10):3679-83. PubMed ID: 908015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of spontaneous mammary carcinomas using direct injections of neuraminidase and BCG.
    Simmons RL; Rios A; Kersey JH
    J Surg Res; 1972 Feb; 12(2):57-61. PubMed ID: 4111004
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of isoniazid on BCG-mediated tumor immunity.
    Romolo JL; Loyd B; Cohen MH
    Surg Forum; 1977; 28():158-9. PubMed ID: 364713
    [No Abstract]   [Full Text] [Related]  

  • 16. Single versus double preoperative intralesional BCG in 13762 mammary adenocarcinoma.
    Lee YT
    J Surg Oncol; 1979; 12(3):243-52. PubMed ID: 502566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
    Kataoka T; Tokunaga T; Murohashi T
    J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition or enhancement of rat mammary tumors dependent on dose BCG.
    Piessens WF; Campbell M; Churchill WH
    J Natl Cancer Inst; 1977 Jul; 59(1):207-11. PubMed ID: 875054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of a prolonged contact with isonicotinic acid hydrazide (INH) on catalase activity of BCG bacilli].
    KWIEK S
    Gruzlica (1926); 1961 Jan; 29():23-4. PubMed ID: 13755550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.